Sun L, Tan M, Cohen RB, Langer CJ, et al. Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor-Based Therapy in Patients With Advanced Non-Small-Cell Lung Cancer. JAMA Oncol 2021 Apr 15. pii: 2778198. doi: 10.1001/jamaoncol.2021.0546.
PMID: 33856403